FDA NDC Directory · JSON-LD · Markdown

LACOSAMIDE

NDC 25021-791 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA214301
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsLACOSAMIDE (10 mg/mL)
Marketing started20220317
Package count1

External sources

Source: openFDA. Public-domain (CC0).